Medicine and Dentistry
Pediatrics
100%
Pediatrics Patient
60%
Cidofovir
50%
Disease
50%
Stem Cell Transplant
50%
Letermovir
50%
Miliary Tuberculosis
50%
Hematopoietic Stem Cell Transplantation
50%
Mevalonate Kinase Deficiency
50%
Psoriasis
50%
Lymphoproliferative Disease
50%
Staphylococcus Lugdunensis
50%
Adenoviridae
50%
Cytomegalovirus
50%
Salvage Therapy
50%
Fulminant
50%
Transplantation
50%
Infection
50%
Cord Blood
43%
Antibiotic Therapy
25%
Antimicrobial Therapy
25%
Public Health
25%
Lung Nodule
25%
Mycobacterium Tuberculosis
25%
Immunosuppressive Treatment
25%
Magnetic Resonance Imaging of Brain
25%
Emergency Department
25%
Mevalonate Kinase
25%
Mycobacteria
25%
Mevalonic Acid
25%
Coughing
25%
Chest Radiograph
25%
Antiinfective Agent
25%
Social Determinants of Health
25%
Community-Acquired Pneumonia
25%
Lung Tuberculosis
25%
Ganciclovir
20%
Foscarnet
20%
Sickle-Cell Disease
20%
In Silico
16%
T Cell
16%
Restriction Mapping
16%
DNA Polymerase
16%
Recombinant
16%
Infusion
16%
Adeno Associated Virus 2
16%
HLA B57 Antigen
16%
Human Adenovirus 5
16%
Human Adenovirus C
16%
Peptide Sequence
16%
Immunology and Microbiology
Metal Binding
50%
Transplant Procedure
50%
Cytotoxicity
50%
Adenoviridae
50%
Antimicrobial Resistance
50%
Antibacterial Activity
50%
Minimum Inhibitory Concentration
50%
DRESS Syndrome
50%
Staphylococcus Lugdunensis
50%
Stem Cell Transplant
50%
Umbilical Cord Blood
33%
HLA B57 Antigen
25%
Verrucomicrobium
16%
Genetic Strain
16%
Human Adenovirus 5
16%
Amino Acid Sequence
16%
Adeno Associated Virus 2
16%
Blood Plasma
16%
Restriction Mapping
16%
DNA Polymerase
16%
Whole Genome Sequencing
16%
Computer Model
16%
Human Adenovirus C
16%
Viral Load
16%
T Cell
16%
Keyphrases
Phylogroup
50%
Prochelator
50%
Cavitary Lesion
50%
Mevalonate Kinase Deficiency
50%
Pediatric Hematopoietic Stem Cell Transplantation
50%
Pediatric Stem Cell Transplant
50%
Quadruple Therapy
25%
Diffuse Opacity
25%
Cephem
21%
Fussiness
16%
Mevalonate Kinase Gene
16%
HLA-B*57
16%
Cardiotonic
16%
Culture Contamination
16%
Right-sided Infective Endocarditis
16%
Mic60
15%
Hemoglobin SS
12%
Secondary Prophylaxis
12%
Letermovir Resistance
12%
Ganciclovir Resistance
12%
Sequence Data Analysis
12%
HAdV-C
12%
E1B-55K
12%
Dual β-lactams
12%
Microbiological Cure
12%
Oxygen Tolerance
10%
Economic Disparities
10%
Metallobiology
7%
Spectroscopic Assay
7%
Bactericidal Efficacy
7%
2-mercaptopyridine
7%
Antibiotic-treated Mice
5%
E. Coli MG1655
5%
Azabicyclo
5%
8-oxo-7
5%
